193 related articles for article (PubMed ID: 33565800)
1. PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer.
Liu YF; Luo D; Li X; Li ZQ; Yu X; Zhu HW
Pancreas; 2021 Feb; 50(2):227-234. PubMed ID: 33565800
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
Zhou C; Yi C; Yi Y; Qin W; Yan Y; Dong X; Zhang X; Huang Y; Zhang R; Wei J; Ali DW; Michalak M; Chen XZ; Tang J
Mol Cancer; 2020 Jul; 19(1):118. PubMed ID: 32727463
[TBL] [Abstract][Full Text] [Related]
3. SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.
Zhang X; Zhao P; Wang C; Xin B
Biochem Biophys Res Commun; 2019 Mar; 510(4):508-514. PubMed ID: 30737032
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207.
You L; Wang H; Yang G; Zhao F; Zhang J; Liu Z; Zhang T; Liang Z; Liu C; Zhao Y
Mol Oncol; 2018 Dec; 12(12):2147-2164. PubMed ID: 30341811
[TBL] [Abstract][Full Text] [Related]
5. A Novel E2F1-EP300-VMP1 Pathway Mediates Gemcitabine-Induced Autophagy in Pancreatic Cancer Cells Carrying Oncogenic KRAS.
Ropolo A; Catrinacio C; Renna FJ; Boggio V; Orquera T; Gonzalez CD; Vaccaro MI
Front Endocrinol (Lausanne); 2020; 11():411. PubMed ID: 32655498
[TBL] [Abstract][Full Text] [Related]
6. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J
Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465
[TBL] [Abstract][Full Text] [Related]
7. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
Sun ZY; Jian YK; Zhu HY; Li B
Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
Ni J; Zhou S; Yuan W; Cen F; Yan Q
J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
[No Abstract] [Full Text] [Related]
9. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
Huang L; Hu C; Cao H; Wu X; Wang R; Lu H; Li H; Chen H
Cell Physiol Biochem; 2018; 47(2):747-758. PubMed ID: 29807360
[TBL] [Abstract][Full Text] [Related]
10. Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis.
Li C; Zhao Z; Zhou Z; Liu R
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1199-1207. PubMed ID: 27785603
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer.
Sun Y; Ren D; Zhou Y; Shen J; Wu H; Jin X
Cell Death Dis; 2021 Sep; 12(10):878. PubMed ID: 34564701
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression.
Shi W; Zhang C; Ning Z; Hua Y; Li Y; Chen L; Liu L; Chen Z; Meng Z
J Exp Clin Cancer Res; 2019 Feb; 38(1):60. PubMed ID: 30728036
[TBL] [Abstract][Full Text] [Related]
15. lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy.
Wang L; Bi R; Li L; Zhou K; Yin H
Aging (Albany NY); 2021 Aug; 13(15):19272-19281. PubMed ID: 34374662
[TBL] [Abstract][Full Text] [Related]
16. MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.
Rajabpour A; Afgar A; Mahmoodzadeh H; Radfar JE; Rajaei F; Teimoori-Toolabi L
Cancer Chemother Pharmacol; 2017 Oct; 80(4):765-775. PubMed ID: 28887583
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells.
You L; Chang D; Du HZ; Zhao YP
Biochem Biophys Res Commun; 2011 Apr; 407(1):1-6. PubMed ID: 21316338
[TBL] [Abstract][Full Text] [Related]
18. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
Chen L; Han X; Hu Z; Chen L
Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1.
Hua YQ; Zhu YD; Xie GQ; Zhang K; Sheng J; Zhu ZF; Ning ZY; Chen H; Chen Z; Meng ZQ; Liu LM
Aging (Albany NY); 2019 Nov; 11(20):8860-8878. PubMed ID: 31619579
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells.
Wang R; Cheng L; Xia J; Wang Z; Wu Q; Wang Z
Curr Cancer Drug Targets; 2014; 14(4):407-17. PubMed ID: 24575976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
